Next Article in Journal
RETRACTED: Lokanath et al. Exploring Chalcone Derivatives as a Multifunctional Therapeutic Agent: Investigating Antioxidant Potential, Acetylcholinesterase Inhibition and Computational Insights. Drugs Drug Candidates 2025, 4, 16
Previous Article in Journal
Synthesis, In Vitro Antitumor Activity, and In Silico ADMET Evaluation of β-Lapachone-Based Thiosemicarbazones
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Singh et al. Synergistic Interaction of Glycyrrhizin with Norfloxacin Displays ROS-Induced Bactericidal Activity against Multidrug-Resistant Staphylococcus aureus. Drugs Drug Candidates 2023, 2, 295–310

1
Molecular Bioprospection Department, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow 226015, India
2
Department of Pharmacology & Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA
*
Author to whom correspondence should be addressed.
Drugs Drug Candidates 2026, 5(1), 2; https://doi.org/10.3390/ddc5010002
Submission received: 19 September 2025 / Accepted: 26 November 2025 / Published: 22 December 2025

References

In the publication [1], reference [49] was mistakenly listed as ‘De Carvalho, P.R.; Furlan, M.; Young, M.C.M.; Kingston, D.G.I.; Bolzani, V.S. Acetylated DNA-damaging clerodane diterpenes from Casearia sylvestris. Phytochemistry 1998, 49, 1659–1662.’. It has been deleted.
Reference [50] was mistakenly listed as ‘Burt, S. Essential oils: Their antibacterial properties and potential applications in foods—A review. Int. J. Food Microbiol. 2004, 94, 223–253.’. It has been deleted.
The last sentence in the third paragraph of Section 2 ‘Results and Discussion’ has been deleted:
‘Cellular damage is characterized by nucleic acid damage [49], apoptosis, and the coagulation of cytoplasmic contents [50].’
With this correction, the order of some references has been adjusted accordingly. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Singh, V.; Pal, A.; Darokar, M.P. Synergistic Interaction of Glycyrrhizin with Norfloxacin Displays ROS-Induced Bactericidal Activity against Multidrug-Resistant Staphylococcus aureus. Drugs Drug Candidates 2023, 2, 295–310. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Singh, V.; Pal, A.; Darokar, M.P. Correction: Singh et al. Synergistic Interaction of Glycyrrhizin with Norfloxacin Displays ROS-Induced Bactericidal Activity against Multidrug-Resistant Staphylococcus aureus. Drugs Drug Candidates 2023, 2, 295–310. Drugs Drug Candidates 2026, 5, 2. https://doi.org/10.3390/ddc5010002

AMA Style

Singh V, Pal A, Darokar MP. Correction: Singh et al. Synergistic Interaction of Glycyrrhizin with Norfloxacin Displays ROS-Induced Bactericidal Activity against Multidrug-Resistant Staphylococcus aureus. Drugs Drug Candidates 2023, 2, 295–310. Drugs and Drug Candidates. 2026; 5(1):2. https://doi.org/10.3390/ddc5010002

Chicago/Turabian Style

Singh, Vigyasa, Anirban Pal, and Mahendra P. Darokar. 2026. "Correction: Singh et al. Synergistic Interaction of Glycyrrhizin with Norfloxacin Displays ROS-Induced Bactericidal Activity against Multidrug-Resistant Staphylococcus aureus. Drugs Drug Candidates 2023, 2, 295–310" Drugs and Drug Candidates 5, no. 1: 2. https://doi.org/10.3390/ddc5010002

APA Style

Singh, V., Pal, A., & Darokar, M. P. (2026). Correction: Singh et al. Synergistic Interaction of Glycyrrhizin with Norfloxacin Displays ROS-Induced Bactericidal Activity against Multidrug-Resistant Staphylococcus aureus. Drugs Drug Candidates 2023, 2, 295–310. Drugs and Drug Candidates, 5(1), 2. https://doi.org/10.3390/ddc5010002

Article Metrics

Back to TopTop